Bio-Path Holdings Expands Global Patent Portfolio
Detailed price information for Bio-Path Holdings (BPTH-Q) from The Globe and Mail including charting and trades.
Bio-Path receives new patents for P-ethoxy nucleic acids
Bio-Path (BPTH) announced the receipt of newly issued patents in the United States and New Zealand, and updated investors on the extent of its ...
AZoNano1d
DNA Hydrogels Based on Takumi-Shaped DNA Nanostructures
Innovative Takumi-shaped DNA hydrogels exhibit prolonged retention and drug release, showcasing their potential as biocompatible delivery systems in medicine.
DNA hydrogels show promise for sustained drug release
Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as sustained-release drug delivery systems as they can encapsulate various ...
Nanowerk1d
Scientists develop innovative DNA hydrogels for sustained drug release
Researchers develop optimized DNA hydrogels using minimized Takumi-shaped DNA nanostructures with potential biomedical applications.
TMCnet2d
Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia
Compelling Patient Response Highlighted by Stable Disease and Significant Reduction in Blast Count After One Treatment Cycle HOUSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ ...
Data-driven techniques enhance understanding of cell division
Research from Umeå University paves the way for a quantitative data analysis method to study the cell division process in ...
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the ...